Trade Summary

1 week ago, VON RICKENBACH JOSEF H, serving as Dir at Rein Therapeutics, Inc. (RNTX), purchased 47,060 shares at $1.05 per share, for a total transaction value of $49,560.64. Following this transaction, VON RICKENBACH JOSEF H now holds 62,514 shares of RNTX.

This purchase represents a 304.52% increase in VON RICKENBACH JOSEF H's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, May 21, 2026 and publicly disclosed via SEC Form 4 filing on Friday, May 29, 2026 at 8:15 PM ET, 8 days after the trade was made.

Rein Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.